EUVIMEDEUVIMED entdecken
Crossref

UNSEEN STRUGGLES: UNDERSTANDING RELAPSING TRANSVERSE MYELITIS IN CHILDREN AND ITS IMPACT ON THEIR FUTURE

Khafifah Puja Atmalia, Dwi Alma Salsabila, Achmad Rafli

Excellence in Pediatrics Abstracts · 04.12.2025 · 17

DOI: 10.66584/eip2025-113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Excellence in Pediatrics Abstracts, online erschienen am 04.12.2025. Verfasst von Khafifah Puja Atmalia und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To educate medical professionals on recognizing symptoms and signs of relapsing myelitis and the management of relapsing myelitis. Case Presentation: A 17-year-old woman presented with sudden-onset lower extremity weakness, sensory changes, urinary retention, and constipation. Physical examination revealed hyperreflexia, weakness in both lower limbs, and sensory loss. MRI of the spine showed a pathological intramedullary spinal intensity area extending throughout the spinal cord from the C2 segment down to T11, suggestive of Multiple Sclerosis or Syringomyelia. The patient also has a history of Sjogren's syndrome. Laboratory investigations were negative for known infectious agents. The patient was initially treated with high-dose corticosteroids, leading to partial recovery. As a result, IVIG was administered. After the acute phase was resolved, the patient was placed on long-term therapy with azathioprine and methylprednisolone. Four months later, the patient experienced similar complaints. In this relapse, high-dose corticosteroids were administered, and the acute phase was resolved. Three months later, the patient experienced a recurrence of symptoms, presenting with similar patterns of rapid-onset weakness, sensory changes, urinary retention, and constipation. MRI again showed a lesion in the central spinal medulla extending from the C2 to Th11 level. After receiving IVIG again, the patient's long-term therapy was changed to mycophenolate mofetil and methylprednisolone.

Conclusion

Although recurrent transverse myelitis in children is rare, it is important to recognize and treat it promptly. A thorough clinical assessment, including an MRI, is essential for identifying the underlying cause and guiding appropriate treatment. Early treatment can enhance recovery and minimize the likelihood of future episodes.

Zitieren

APA

Atmalia, K. P., Salsabila, D. A., & Rafli, A. (2025). UNSEEN STRUGGLES: UNDERSTANDING RELAPSING TRANSVERSE MYELITIS IN CHILDREN AND ITS IMPACT ON THEIR FUTURE. Excellence in Pediatrics Abstracts, 17. https://doi.org/10.66584/eip2025-113

Vancouver

Atmalia KP, Salsabila DA, Rafli A. UNSEEN STRUGGLES: UNDERSTANDING RELAPSING TRANSVERSE MYELITIS IN CHILDREN AND ITS IMPACT ON THEIR FUTURE. Excellence in Pediatrics Abstracts. 2025;17. doi:10.66584/eip2025-113

BibTeX
@article{Atmalia2025,
  author = {Atmalia, Khafifah Puja and Salsabila, Dwi Alma and Rafli, Achmad},
  title = {UNSEEN STRUGGLES: UNDERSTANDING RELAPSING TRANSVERSE MYELITIS IN CHILDREN AND ITS IMPACT ON THEIR FUTURE},
  journal = {Excellence in Pediatrics Abstracts},
  year = {2025},
  volume = {17},
  doi = {10.66584/eip2025-113}
}
Kostenlos starten →